These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 475947)

  • 1. The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.
    Lee DA; Taylor GM; Walker JG; James VH
    Br J Clin Pharmacol; 1979 May; 7(5):523-8. PubMed ID: 475947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prednisolone levels in man following administration in plain and enteric-coated forms.
    Wilson CG; May CS; Paterson JW
    Br J Clin Pharmacol; 1977 Jun; 4(3):351-5. PubMed ID: 901703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.
    Morrison PJ; Bradbrook ID; Rogers HJ
    Br J Clin Pharmacol; 1977 Oct; 4(5):597-603. PubMed ID: 911606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets.
    Al-Habet SM; Rogers HJ
    Eur J Clin Pharmacol; 1989; 37(4):423-6. PubMed ID: 2598978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.
    Henderson RG; Wheatley T; English J; Chakraborty J; Marks V
    Br Med J; 1979 Jun; 1(6177):1534-6. PubMed ID: 380747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of enteric and non-enteric coated prednisolone tablets.
    Hulme B; James VH; Rault R
    Br J Clin Pharmacol; 1975 Aug; 2(4):317-20. PubMed ID: 1233990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent administration of cimetidine and enteric-coated prednisolone: effect on plasma levels of prednisolone.
    Morrison PJ; Rogers HJ; Bradbrook ID; Parsons C
    Br J Clin Pharmacol; 1980 Jul; 10(1):87-9. PubMed ID: 7397059
    [No Abstract]   [Full Text] [Related]  

  • 8. Enteric coated quinidine compared to sustained release preparations during repeated administration.
    Bakke OM; Aanderud L; Aslaksen A
    Acta Med Scand; 1980; 207(3):183-7. PubMed ID: 7368984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets.
    Adair CG; McCallion O; McElnay JC; Scott MG; Hamilton BA; McCann JP; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1992 May; 33(5):495-9. PubMed ID: 1524961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric-coated tablets improve oral bioavailability of DX-9065, a novel anticoagulant.
    Fujii Y; Kanamaru T; Kikuchi H; Yamashita S; Sakuma S
    Eur J Pharm Sci; 2011 Mar; 42(4):392-9. PubMed ID: 21238588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of enteric-coated penicillamine tablets.
    Chambliss WG; Chambliss DA; Cleary RW; Jones AB; Harland EC; Kibbe AH
    J Pharm Sci; 1984 Sep; 73(9):1215-9. PubMed ID: 6333505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of plasma levels of prednisolone after oral administration in man.
    Leclercq R; Copinschi G
    J Pharmacokinet Biopharm; 1974 Apr; 2(2):175-87. PubMed ID: 4427221
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of quinidine from an enteric-coated preparation.
    Fremstad D; Nilsen OG; Amlie J; Storstein L; Olsson B; Jacobsen S
    Eur J Clin Pharmacol; 1979 Sep; 16(2):107-12. PubMed ID: 499306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
    Walter K; von Nieciecki A
    Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation.
    Debunne A; Vervaet C; Mangelings D; Remon JP
    Eur J Pharm Sci; 2004 Jul; 22(4):305-14. PubMed ID: 15196587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.